ID   LDR2a
AC   CVCL_V119
SY   LDR2A
DR   CLO; CLO_0007291
DR   CLDB; cl3196
DR   IHW; 11w 8105
DR   Wikidata; Q54902387
RX   PubMed=3128633;
CC   Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4947; HLA-DRA.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4953; HLA-DRB5.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q9QNF7; Human herpesvirus 1 TK.
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4536 ! L-M(TK-)
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 13
//
RX   PubMed=3128633; DOI=10.1084/jem.167.4.1442; PMCID=PMC2188916;
RA   Wilkinson D., de Vries R.R.P., Madrigal J.A., Lock C.B.,
RA   Morgenstern J.P., Trowsdale J., Altmann D.M.;
RT   "Analysis of HLA-DR glycoproteins by DNA-mediated gene transfer.
RT   Definition of DR2 beta gene products and antigen presentation to T
RT   cell clones from leprosy patients.";
RL   J. Exp. Med. 167:1442-1458(1988).
//